Pricing Log in Create free account

Jaguar Animal Health, Inc. (JAGX) vs NKGen Biotech, Inc. (NKGN)

Jaguar Animal Health, Inc. and NKGen Biotech, Inc. are both Biotechnology companies. Jaguar Animal Health, Inc. and NKGen Biotech, Inc. are of similar size ($8.9M and $8.8M). NKGen Biotech, Inc. has negative trailing earnings, so its P/E is not meaningful; Jaguar Animal Health, Inc. trades at 0.0×. NKGen Biotech, Inc. has the higher net margin (0.00% vs −188.5%) and the higher return on invested capital (0.00% vs −28,393.6%). Across the 12 metrics below, NKGen Biotech, Inc. leads on 7 and Jaguar Animal Health, Inc. on 5.

Valuation

Metric JAGX NKGN Biotechnology median
P/E 0.00 n/m 8.50
P/S 0.01 n/m 9.71
P/B 0.04 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.13 n/m 0.64
EV/Sales (0.11) n/m 9.21
Earnings yield 51,230.90% (10,600.00%) (33.15%)
Free cash flow yield (3,867.38%) (4,296.38%) (25.50%)

Profitability

Metric JAGX NKGN Biotechnology median
Gross margin 82.31% — 65.16%
Operating margin (93.10%) 0.00% 0.00%
Net margin (188.46%) 0.00% 0.00%
Free cash flow margin (24.03%) 0.00% 0.00%
Return on equity (1,125.38%) 44.70% (56.36%)
Return on assets (127.14%) (146.49%) (48.04%)
Return on invested capital (28,393.64%) 0.00% 0.00%

Growth

Metric JAGX NKGN Biotechnology median
Revenue growth (TTM) 135.52% — 6.02%
EPS growth (last fiscal year) 82.42% 71.38% 30.26%
Revenue growth, 5-year CAGR 4.17% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric JAGX NKGN Biotechnology median
Debt to equity 0.35 (0.59) 0.00
Current ratio 0.69 0.05 4.72
Net debt to EBITDA (0.17) (1.69) 0.96

Dividend

Metric JAGX NKGN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric JAGX NKGN Biotechnology median
Market cap 8.93m 8.76m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack